Real-world data show a rise in biomarker testing for primary advanced/recurrent endometrial cancer, especially mismatch repair/microsatellite instability, but disparities in access persist across care...
In this interview, Jeffrey Levine, MD, MPH, previews his Practical Updates in Primary Care 2025 presentation on managing menopause across life stages. He discusses the impact of hormonal changes on mental...
A new study from Mayo Clinic and Exact Sciences demonstrates that a six-gene methylated DNA marker panel, detectable in vaginal fluid, accurately identifies endometrial cancer in women with abnormal uterine...
A retrospective cohort study found that endometrial biopsies identifying endometrial intraepithelial neoplasia were associated with a higher likelihood of endometrial cancer and high-risk features on final...
A study that was presented at the American College of Cardiology's 74th Annual Scientific Session & Expo in Chicago, IL found that midlife women using a mobile health app had higher engagement and...
A study identified biomarkers associated with response and resistance to nivolumab plus cabozantinib in recurrent endometrial cancer, offering insights for future therapies.
A randomized trial found a minor overall survival benefit for robotic-assisted laparoscopy over coheanventional laparoscopy in endometrial cancer treatment.
A new analysis found no difference in cardiovascular event rates between immediate and deferred antiretroviral therapy initiation among adults with HIV who had high CD4+ counts and low baseline...
Researchers developed a population-based cohort study to determine whether there are associations between endometriosis subtypes and incidence of ovarian cancer.
A recent ancillary analysis of the LANCE trial examined the feasibility and perioperative outcomes of hyperthermic intraperitoneal chemotherapy in patients undergoing minimally invasive surgery compared...
